Semapimod Mesylate

N/A

Report date: 2023/04/21 09:51:03
NME

Base Information

Drug NameSemapimod Mesylate
Drug Alias Name甲磺酸塞玛莫德semapimodum塞马莫德甲磺酸盐塞玛莫德甲磺酸盐甲磺酸塞马莫德 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokines inhibitorsNitric oxide inhibitorsC-Raf kinase inhibitors
TargetsCytokinesC-Raf kinase
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFerring Bv
Active IndicationsN/A
Inactive IndicationsCrohn Disease

Other Information

ATC CodeN/A
Related LinksWikipedia